IPO Issue Details
Issue Price / Price Band₹159 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size800 Shares per Lot
Total Issue Size67,52,000 shares (aggregating up to ₹107.27 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenMon, 10 Feb 2025
Subscription CloseWed, 12 Feb 2025
Anchor AllotmentSun, 09 Feb 2025
Basis of AllotmentThu, 13 Feb 2025
Initiation of RefundsFri, 14 Feb 2025
Credit of Shares to DematFri, 14 Feb 2025
Listing DateMon, 17 Feb 2025
UPI Mandate Deadline2025-02-12
Application & Investment Details
Retail — Min (1 Lots)₹1,27,200 — 800 shares
Retail — Max (13 Lots)₹1,653,600 (13 Lots)
HNI — Min (2 Lots)₹2,54,400 — 1,600 shares
EPS (Pre-IPO)₹8.18
EPS (Post-IPO)₹9.50
P/E Ratio (Pre-IPO)19.44x
P/E Ratio (Post-IPO)16.74x
Net Offer to Public64,12,800 shares (aggregating up to ₹101.88 Cr)
Reserved for Market Maker3,39,200 shares (aggregating up to ₹5.39 Cr)
Pre-IPO Promoter Holding2,00,00,000 shares
Post-IPO Promoter Holding2,44,52,064 shares
Fresh Issue Shares41,12,864 shares (aggregating up to ₹65.34 Cr)
Offer for Sale Shares22,99,936 shares of ₹10 (aggregating up to ₹36.54 Cr)
About Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand.As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans.The radiology facilities have eleven CT scanners and four MRI machines.As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals.Products and services:The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.Routine Pathology TestsSpecialized Pathology TestsRadiology TestsPreventive and Wellness ServicesHome Collection ServiceCompetitive Strength:Strong geographic presence in Uttarakhand, including 39 tier-two cities and towns.Integrated diagnostics provider offering pathology, radiology testing, and medical consultations.Track record of profitability and consistent financial performance.Dedicated management team with significant industry experience.
Objects of the Issue
Chandan Healthcare Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
2
Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh
3
Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
4
General corporate purposes.
Shareholding & Lock-in
Pre-IPO Promoter Holding
2,00,00,000 shares
Post-IPO Promoter Holding
2,44,52,064 shares